FIGURE 3.

Network meta-analysis of all-cause mortality (blue), adverse events (light red) serious adverse events (red). Pharmacological treatments are reported in alphabetical order. Comparisons should be read from left to right. All-cause mortality and safety estimates are located at the intersection between the column-defining and the row-defining treatment. For all-cause mortality, RRs above 1 favor the column-defining treatment. For safety, RRs above 1 favor the row-defining treatment. We incorporated the GRADE judgments in the figure. Estimates in gray have a very low or low certainty of evidence.